- Home
- ARQQ vs DRRX Comparison
ARQQ vs DRRX Comparison
Compare ARQQ & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- DRRX
- Stock Information
- Founded
- ARQQ 2017
- DRRX 1998
- Country
- ARQQ United Kingdom
- DRRX United States
- Employees
- ARQQ N/A
- DRRX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- DRRX Health Care
- Exchange
- ARQQ Nasdaq
- DRRX Nasdaq
- Market Cap
- ARQQ 51.8M
- DRRX 44.4M
- IPO Year
- ARQQ N/A
- DRRX 2000
- Fundamental
- Price
- ARQQ $10.65
- DRRX $0.86
- Analyst Decision
- ARQQ Strong Buy
- DRRX Buy
- Analyst Count
- ARQQ 1
- DRRX 2
- Target Price
- ARQQ $50.00
- DRRX $5.00
- AVG Volume (30 Days)
- ARQQ 212.7K
- DRRX 83.1K
- Earning Date
- ARQQ 12-03-2024
- DRRX 11-13-2024
- Dividend Yield
- ARQQ N/A
- DRRX N/A
- EPS Growth
- ARQQ N/A
- DRRX N/A
- EPS
- ARQQ N/A
- DRRX N/A
- Revenue
- ARQQ $740,000.00
- DRRX $8,594,000.00
- Revenue This Year
- ARQQ $341.56
- DRRX N/A
- Revenue Next Year
- ARQQ $274.91
- DRRX $3.07
- P/E Ratio
- ARQQ N/A
- DRRX N/A
- Revenue Growth
- ARQQ N/A
- DRRX N/A
- 52 Week Low
- ARQQ $3.72
- DRRX $0.48
- 52 Week High
- ARQQ $23.00
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- ARQQ 52.47
- DRRX 25.34
- Support Level
- ARQQ $7.00
- DRRX $0.82
- Resistance Level
- ARQQ $8.15
- DRRX $1.36
- Average True Range (ATR)
- ARQQ 1.09
- DRRX 0.13
- MACD
- ARQQ -0.05
- DRRX -0.05
- Stochastic Oscillator
- ARQQ 40.14
- DRRX 6.45
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .